Biotech company Illumina pushes back against Carl Icahn’s proxy fight over $7.1 billion Grail deal
March 20, 2023 at 12:43 PM EDT
Illumina pushed back against Carl Icahn's proxy fight over the Grail deal, saying it's committed to maximizing shareholder value as it works with regulators.
